SRPT

#1698
Sarepta Therapeutics, Inc. - Common Stock
17.8 7 USD
+3.24%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
17.87
17.87
Intervallo Annuale
10.41
43.91
Variazione giornaliera
+3.24%
Variazione Mensile
-14.78%
Variazione di 6 mesi
-14.74%
Variazione Annuale
-53.04%
Chiusura Precedente
17.3 1
Open
17.8 7
Minimo
17.8 7
High
17.8 7
Volume
188
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 1.89 B
  • Employee 835
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.02
Rapporto prezzo/fatturato
0.98

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

Notizie